Patent Yard Sign in
Expired Canadian patentCanada

Ester prodrugs of steroids

CA 1310009 C · Owner: Braughler, John Mark · Inventors: Hall, Edward Dallas; Mccall, John Michael; Wierenga, Wendell

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A compound of the formula wherein the dotted line between positions C-1 and C-2 means the presence or absence of a double bond;, wherein R1 is CH3 or -C2H5; wherein R2 is H, and R3 is in the .alpha.-position and is -OH -O-alkyl(C1-C12), -O?alkyl(C1-C12), =O?aryl -C?N(R)2, or -O?OR7, wherein aryl is furyl thienyl, pyrrolyl, or pyridyl wherein each of said hetero moiety is optionally substituted with one or two (C1-C4)alkyl groups or aryl is -(CH2)f-phenyl wherein f is 0 to 2 and wherein the phenyl ring is optionally substituted with 1 to 3 groups selected from chlorine, fluorine, bromine, alkyl(C1-C3) alkoxy(C1-C3), thio-, alkoxy(C1-C3), Cl3C- F3C-, -NH2 and -NHCOCH3 and wherein R is …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted November 10, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 10, 2009.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 13, 1985
GrantedNovember 10, 1992
Term endedNovember 10, 2009
Patent numberCA 1310009 C
Classification (IPC)C07J5/00 +2 more

Timeline

Timeline From CIPO dates

19861989199219951998200120042007Application filedMarch 13, 1985Patent grantedNov 10, 1992Term endedNov 10, 2009

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.